Cargando…
Utility of a single mid-trimester measurement of plasminogen activator Type 1 and fibronectin to predict preeclampsia in pregnancy
BACKGROUND: Preeclampsia (PE) is the second most common cause of maternal death after obstetric hemorrhage in Africa, a resource-limited region. This study was designed to examine the potential usefulness of a single screening plasma plasminogen activator inhibitor-1 (PAI-1) and fibronectin (FN) lev...
Autores principales: | Ajibola, S. O., Adeyemo, T. A., Afolabi, B. B., Akanmu, A. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995812/ https://www.ncbi.nlm.nih.gov/pubmed/27630384 http://dx.doi.org/10.4103/0300-1652.188337 |
Ejemplares similares
-
Fibronectin, Plasminogen Activator Inhibitor Type 1 (PAI-1) And Uterine Artery Doppler Velocimetry as Markers of Preeclampsia
por: Bodova, Kristina Biskupska, et al.
Publicado: (2011) -
Hemostasis System and Plasminogen Activity in Retrochorial Hematoma in the First Trimester of Pregnancy
por: Tikhonova, Natalia B., et al.
Publicado: (2022) -
Non-Coding RNAs and Prediction of Preeclampsia in the First Trimester of Pregnancy
por: Ogoyama, Manabu, et al.
Publicado: (2022) -
Prevalence and type of monoclonal gammopathy of undetermined significance in an apparently healthy Nigerian population: a cross sectional study
por: Onwah, A Lawretta, et al.
Publicado: (2012) -
Mid-trimester cesarean scar pregnancy: a case report
por: Fowler, Mary Louise, et al.
Publicado: (2021)